|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Russo AE and Strong VE: Gastric cancer
etiology and management in Asia and the West. Annu Rev Med.
70:353–367. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Irino T, Takeuchi H, Terashima M, Wakai T
and Kitagawa Y: Gastric cancer in Asia: Unique features and
management. Am Soc Clin Oncol Educ Book. 37:279–291. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L and Zhang K: Surgical treatment for
metastatic gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi.
20:731–734. 2017.(In Chinese). PubMed/NCBI
|
|
5
|
Li S and Le W: An insight review of
autophagy biology and neurodegenerative diseases: Machinery,
mechanisms and regulation. Sci China Life Sci. 60:1457–1459. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin Z, Pascual C and Klionsky DJ:
Autophagy: Machinery and regulation. Microb Cell. 3:588–596. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fulda S: Targeting autophagy for the
treatment of cancer. Biol Chem. 399:673–677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian Y, Xu H, Farooq AA, Nie B, Chen X, Su
S, Yuan R, Qiao G, Li C, Li X, et al: Maslinic acid induces
autophagy by down-regulating HSPA8 in pancreatic cancer cells.
Phytother Res. 32:1320–1331. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu J, Feng L, Zhang H, Zhang J, Zhang Y,
Li S, Qin L, Yang Z and Xiong J: Effects of miR-144 on the
sensitivity of human anaplastic thyroid carcinoma cells to
cisplatin by autophagy regulation. Cancer Biol Ther. 19:484–496.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song J, Zhou Y, Gong Y, Liu H and Tang L:
Rottlerin promotes autophagy and apoptosis in gastric cancer cell
lines. Mol Med Rep. 18:2905–2913. 2018.PubMed/NCBI
|
|
11
|
Liu D, Gao M and Zhao S: Autophagy as a
novel strategy for treatment of gastric cancer: A hypothesis. Med
Sci Monit. 19:794–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li LQ, Pan D, Zhang SW, Xie DY, Zheng XL
and Chen H: Autophagy regulates chemoresistance of gastric cancer
stem cells via the Notch signaling pathway. Eur Rev Med Pharmacol
Sci. 22:3402–3407. 2018.PubMed/NCBI
|
|
13
|
Bai XY, Liu YG, Song W, Li YY, Hou DS, Luo
HM and Liu P: Anticancer activity of tetrandrine by inducing
pro-death apoptosis and autophagy in human gastric cancer cells. J
Pharm Pharmacol. 70:1048–1058. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan H, Jiang M, Li B, He Y, Huang C, Luo
D, Xu H, Yang L and Zhou J: MicroRNA-let-7a regulates cell
autophagy by targeting Rictor in gastric cancer cell lines MGC-803
and SGC-7901. Oncol Rep. 39:1207–1214. 2018.PubMed/NCBI
|
|
15
|
Li B, Wang W, Li Z, Chen Z, Zhi X, Xu J,
Li Q, Wang L, Huang X, Wang L, et al: MicroRNA-148a-3p enhances
cisplatin cytotoxicity in gastric cancer through mitochondrial
fission induction and cyto-protective autophagy suppression. Cancer
Lett. 410:212–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee J, Giordano S and Zhang J: Autophagy,
mitochondria and oxidative stress: Cross-talk and redox signalling.
Biochem J. 441:523–540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun T: Long noncoding RNAs act as
regulators of autophagy in cancer. Pharmacol Res. 129:151–155.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Zhu M, Sun Y, Li W, Wang Y and Yu
W: Upregulation of lncRNA CASC2 suppresses cell proliferation and
metastasis of breast cancer via inactivation of the TGF-β signaling
pathway. Oncol Res. 27:379–387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ,
Hsu CW, Chen WS and Wang JH: Linc00659, a long noncoding RNA, acts
as novel oncogene in regulating cancer cell growth in colorectal
cancer. Mol Cancer. 17:722018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma J, Wu K, Liu K and Miao R: Effects of
MALAT1 on proliferation and apo- ptosis of human non-small cell
lung cancer A549 cells in vitro and tumor xenograft growth in vivo
by modulating autophagy. Cancer Biomark. 22:63–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C, Cui Y, Liu LF, Ren WB, Li QQ, Zhou
X, Li YL, Li Y, Bai XY and Zu XB: High expression of long noncoding
RNA MALAT1 indicates a poor prognosis and promotes clinical
progression and metastasis in bladder cancer. Clin Genitourin
Cancer. 15:570–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang CJ, Shi SB, Tian J, Xu J and Niu ZX:
lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the
efficacy of GEM based chemotherapy in first-line treatment of
pancreatic cancer patients. Oncotarget. 8:95108–95115.
2017.PubMed/NCBI
|
|
26
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shuai F, Wang B and Dong S: MicroRNA-204
inhibits the growth and motility of colorectal cancer cells by
downregulation of CXCL8. Oncol Res. 26:1295–1305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shu L, Zhang Z and Cai Y: MicroRNA-204
inhibits cell migration and invasion in human cervical cancer by
regulating transcription factor 12. Oncol Lett. 15:161–166.
2018.PubMed/NCBI
|
|
29
|
Shu Y, Ren L, Xie B, Liang Z and Chen J:
MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated
prostate cancer cells by targeting SIRT1/p53 pathway. Oncotarget.
8:97313–97322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen SQ, Huang LS, Xiao XL, Zhu XF, Xiong
DD, Cao XM, Wei KL, Chen G and Feng ZB: MiR-204 regulates the
biological behavior of breast cancer MCF-7 cells by directly
targeting FOXA1. Oncol Rep. 38:368–376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Canu V, Sacconi A, Lorenzon L, Biagioni F,
Lo Sardo F, Diodoro MG, Muti P, Garofalo A, Strano S, D'Errico A,
et al: MiR-204 down-regulation elicited perturbation of a gene
target signature common to human cholangiocarcinoma and gastric
cancer. Oncotarget. 8:29540–29557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li T, Pan H and Li R: The dual regulatory
role of miR-204 in cancer. Tumour Biol. 37:11667–11677. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shrestha S, Yang CD, Hong HC, Chou CH, Tai
CS, Chiew MY, Chen WL, Weng SL, Chen CC, Chang YA, et al:
Integrated microRNA-mRNA analysis reveals miR-204 inhibits cell
proliferation in gastric cancer by targeting CKS1B, CXCL1 and
GPRC5A. Int J Mol Sci. 19(pii): E872017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Liu XS, Liu HY, Lu YY and Li Y:
Reduced expression of serum miR-204 predicts poor prognosis of
gastric cancer. Genet Mol Res. 15:2016.
|
|
35
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Wang J, Chen Y, Li S, Jin M, Wang H,
Chen Z and Yu W: LncRNA MALAT1 exerts oncogenic functions in lung
adenocarcinoma by targeting miR-204. Am J Cancer Res. 6:1099–1107.
2016.PubMed/NCBI
|
|
37
|
Tan X, Huang Z and Li X: Long non-coding
RNA MALAT1 interacts with miR-204 to modulate human hilar
cholangiocarcinoma proliferation, migration, and invasion by
targeting CXCR4. J Cell Biochem. 118:3643–3653. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen T, Yang K, Yu J, Meng W, Yuan D, Bi
F, Liu F, Liu J, Dai B, Chen X, et al: Identification and expansion
of cancer stem cells in tumor tissues and peripheral blood derived
from gastric adenocarcinoma patients. Cell Res. 22:248–258. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao W, Chang C, Cui Y, Zhao X, Yang J,
Shen L, Zhou J, Hou Z, Zhang Z, Ye C, et al: Steroid receptor
coactivator-3 regulates glucose metabolism in bladder cancer cells
through coactivation of hypoxia inducible factor 1α. J Biol Chem.
289:11219–11229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yin JJ, Liang B and Zhan XR: MicroRNA-204
inhibits cell proliferation in T-cell acute lymphoblastic leukemia
by down-regulating SOX4. Int J Clin Exp Pathol. 8:9189–9195.
2015.PubMed/NCBI
|
|
41
|
Bolanos JM, Moran AM, da Silva CM, Dávila
MP, Muñoz PM, Aparicio IM, Tapia JA, Ferrusola CO and Peña FJ:
During cooled storage the extender influences processed autophagy
marker light chain 3 (LC3B) of stallion spermatozoa. Anim Reprod
Sci. 145:40–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
YiRen H, YingCong Y, Sunwu Y, Keqin L,
Xiaochun T, Senrui C, Ende C, XiZhou L and Yanfan C: Long noncoding
RNA MALAT1 regulates autophagy associated chemoresistance via
miR-23b-3p sequestration in gastric cancer. Mol Cancer. 16:1742017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chung KW, Kim KM, Choi YJ, An HJ, Lee B,
Kim DH, Lee EK, Im E, Lee J, Im DS, et al: The critical role played
by endotoxin-induced liver autophagy in the maintenance of lipid
metabolism during sepsis. Autophagy. 13:1113–1129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moscat J and Diaz-Meco MT: p62 at the
crossroads of autophagy, apoptosis, and cancer. Cell.
137:1001–1004. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Moscat J and Diaz-Meco MT: p62: A
versatile multitasker takes on cancer. Trends Biochem Sci.
37:230–236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu Z, Long J, Du R, Ge C, Guo K and Xu Y:
MiR-204 regulates the EMT by targeting snai1 to suppress the
invasion and migration of gastric cancer. Tumour Biol.
37:8327–8335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hou Z, Xu X, Zhou L, Fu X, Tao S, Zhou J,
Tan D and Liu S: The long non-coding RNA MALAT1 promotes the
migration and invasion of hepatocellular carcinoma by sponging
miR-204 and releasing SIRT1. Tumour Biol. 39:10104283177181352017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hall DP, Cost NG, Hegde S, Kellner E,
Mikhaylova O, Stratton Y, Ehmer B, Abplanalp WA, Pandey R, Biesiada
J, et al: TRPM3 and miR-204 establish a regulatory circuit that
controls oncogenic autophagy in clear cell renal cell carcinoma.
Cancer Cell. 26:738–753. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cost NG and Czyzyk-Krzeska MF: Regulation
of autophagy by two products of one gene: TRPM3 and miR-204. Mol
Cell Oncol. 2:e10027122015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang S, Yu W, Luo X, Chen J and Deng F:
MALAT1/miR-204/LC3-II: A potential regulated axis of autophagy in
myocardial ischemia-reperfusion injury. Int J Cardiol. 277:2222019.
View Article : Google Scholar : PubMed/NCBI
|
